
Solvac S.A (SOLV) | Financial Analysis & Statements
Solvac S.A. | Large-cap | Basic Materials
Solvac S.A. | Large-cap | Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
219.0M
Shareholders Equity
2.5B
Debt to Equity
0.09
Cash Flow Metrics
Revenue & Profitability Trend
Solvac S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Goods Sold | 2.1M | 2.0M | 1.6M | - | - |
Gross Profit | -2.1M | -2.0M | -1.6M | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | 105.0K | 105.0K | 101.0K | 2.0M | 4.0M |
Total Operating Expenses | 105.0K | 105.0K | 101.0K | 2.0M | 4.0M |
Operating Income | -2.5M | -2.6M | -1.9M | -2.0M | -4.0M |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | 290.0K | 0 | 0 | - | - |
Interest Expense | 3.4M | 3.1M | 2.9M | 3.0M | 4.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 104.7M | 127.3M | 122.0M | 293.0M | -312.0M |
Income Tax | -400 | -400 | 0 | - | - |
Effective Tax Rate % | -0.0% | -0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 104.7M | 127.3M | 122.0M | 293.0M | -312.0M |
Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Key Metrics | |||||
EBITDA | 108.7M | 132.7M | 124.9M | 296.0M | -308.0M |
EPS (Basic) | - | €5.96 | €5.71 | €13.70 | €-14.60 |
EPS (Diluted) | - | €5.96 | €5.71 | €13.70 | €-14.60 |
Basic Shares Outstanding | - | 21366275 | 21369527 | 21375033 | 21375033 |
Diluted Shares Outstanding | - | 21366275 | 21369527 | 21375033 | 21375033 |
Income Statement Trend
Solvac S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.2M | 4.2M | 736.0K | 0 | 0 |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 0 | 0 | 0 | 49.0M | 49.0M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | 1.0K | - | - |
Total Current Assets | 35.1M | 57.3M | 51.0M | 49.0M | 49.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 19.9K | 10.0K | 11.0K | - | - |
Goodwill | 0 | 1.0K | 343.0M | 686.0M | 686.0M |
Intangible Assets | - | 1.0K | 6.0K | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | -421 | - | 1.0K | - | - |
Total Non-Current Assets | 2.7B | 2.7B | 2.7B | 3.1B | 2.6B |
Total Assets | 2.7B | 2.8B | 2.7B | 3.1B | 2.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 172.0K | 1.6M | 79.0K | - | - |
Short-term Debt | 63.0M | 48.6M | 48.0M | 50.0M | 51.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 52.0M | 2.4M | 2.4M | 4.0M | 4.0M |
Total Current Liabilities | 116.4M | 69.0M | 65.9M | 67.0M | 68.0M |
Non-Current Liabilities | |||||
Long-term Debt | 100.0M | 150.0M | 150.0M | 150.0M | 150.0M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | -304 | -1.0K | 1.0K | - | - |
Total Non-Current Liabilities | 100.0M | 150.0M | 150.0M | 150.0M | 150.0M |
Total Liabilities | 216.4M | 219.0M | 215.9M | 217.0M | 218.0M |
Equity | |||||
Common Stock | 192.8M | 192.8M | 192.8M | 192.0M | 192.0M |
Retained Earnings | 1.4B | 1.4B | 1.4B | 1.9B | 1.8B |
Treasury Stock | - | - | 0 | 0 | 0 |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.5B | 2.5B | 2.5B | 2.9B | 2.4B |
Key Metrics | |||||
Total Debt | 163.0M | 198.6M | 198.0M | 200.0M | 201.0M |
Working Capital | -81.2M | -11.8M | -14.9M | -18.0M | -19.0M |
Balance Sheet Composition
Solvac S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | - | - | 594.0M | 293.0M | -312.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
Operating Cash Flow | - | - | 597.0M | 296.0M | -308.0M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | 0 | 0 | -8.0M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | - | - | 0 | 0 | -8.0M |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | 0 |
Dividends Paid | - | - | -119.0M | -116.0M | -116.0M |
Debt Issuance | 13.0M | 48.6M | 48.0M | 50.0M | 51.0M |
Debt Repayment | -48.6M | -48.0M | -50.0M | -51.0M | -40.0M |
Financing Cash Flow | -35.6M | 600.0K | -121.0M | -117.0M | -105.0M |
Free Cash Flow | -3.1M | -4.7M | 125.0M | 120.0M | 117.0M |
Net Change in Cash | -35.6M | 600.0K | 476.0M | 179.0M | -421.0M |
Cash Flow Trend
Solvac S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
18.98
Forward P/E
6.97
Price to Book
0.79
Price to Sales
397,575.00
PEG Ratio
6.97
Profitability Ratios
Profit Margin
2,093,960.00%
Operating Margin
100.69%
Return on Equity
4.15%
Return on Assets
-0.06%
Financial Health
Current Ratio
0.30
Debt to Equity
7.83
Beta
0.77
Per Share Data
EPS (TTM)
€4.90
Book Value per Share
€117.73
Revenue per Share
€0.00
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
solv | 2.0B | 18.98 | 0.79 | 4.15% | 2,093,960.00% | 7.83 |
Syneos Health | 7.4B | 377.86 | 1.20 | -1.20% | -1.30% | 45.57 |
Solvay SA | 2.9B | 21.42 | 2.57 | 11.13% | 2.81% | 185.12 |
Azelis Group NV | 3.2B | 19.29 | 1.22 | 6.41% | 4.01% | 77.22 |
Titan Cement | 2.7B | 12.96 | 1.49 | 12.28% | 7.88% | 36.26 |
Tessenderlo Group NV | 1.6B | 38.57 | 0.86 | 2.28% | 1.62% | 13.46 |
Financial data is updated regularly. All figures are in the company's reporting currency.